News

Du hast Fragen zu unseren News?

Hier findest du unsere Ansprechpartner für die Presse- und Öffentlichkeitsarbeit:

To press contacs
All news
Corporate
Brands
Sports
R&D

Dr. Wolff continues to grow and targets 400 million euros turnover with new health products

Read more
03.01.2023

Dr. Wolff continues to grow and targets 400 million euros turnover with new health products

Despite generally difficult global conditions and a noticeable decline in the hygiene and disinfection market, Dr. Wolff Group again increased sales in the past year.

Read more

Dr. Wolff informs with platform “NervtDichDeinSchwitzen.de” about illness hyperhidrosis

Read more
25.11.2022

Dr. Wolff informs with platform “NervtDichDeinSchwitzen.de” about illness hyperhidrosis

Sweating. A vital process, but when people feel they sweat too much, it becomes a burden. Most of all for those who suffer from so-called primary hyperhidrosis – a condition that is characterised by excessively sweating for no apparent reason. To raise awareness of hyperhidrosis among the general public Dr. Wolff launched a digital information platform succinctly named nervtdichdeinschwitzen.de (= does your sweating annoy you)

Read more

Asia-Pacific Conference in Singapore Meets World’s Biggest Shopping Event “Singles Day“

Read more
18.11.2022

Asia-Pacific Conference in Singapore Meets World’s Biggest Shopping Event “Singles Day“

Despite the pandemic and the lockdown, Bielefeld-based family company Dr. Wolff sees great potential in the Asian market and is consistently expanding its commitment there.

Read more

Dr. Wolff Group increases turnover again in 2021 to a new record level – 2022 off to a good start despite global crises

Read more
28.06.2022

Dr. Wolff Group increases turnover again in 2021 to a new record level – 2022 off to a good start despite global crises

The Bielefeld-based Dr. Wolff Group recorded the highest turnover to date in the company’s 117-year history at 357.2 million euros (2020: 341.1 million euros), achieved a plus of almost five percent and increased turnover despite Corona in the past two years.

Read more

First anticholinergic cream against heavy underarm sweating currently approved in 11 European countries

Read more
30.05.2022

First anticholinergic cream against heavy underarm sweating currently approved in 11 European countries

Eleven countries have granted marketing authorisation for the topical cream containing 1% glycopyrronium bromide (brand name Axhidrox). The gradual market launch of the product in the respective countries is in preparation.

Read more

Dr. Wolff Group continues successful course in the areas of hair, skin and dental health

Read more
03.01.2022

Dr. Wolff Group continues successful course in the areas of hair, skin and dental health

With an increase to 355 million euros in preliminary turnover the family-owned company successfully stood up to the second year of the pandemic and has increased sales by around 42 million euros since 2019.

Read more

Still on course and defying the crisis with an enormous effort

Read more
22.04.2021

Still on course and defying the crisis with an enormous effort

In 2020, Bielefeld-based Dr. Wolff Group recorded a turnover of 341.1 million euros (2019: 313.4 million euros), an increase of about nine percent, with exports continuing to account for more than 20 percent.

Read more

Alcina hair division and caring cosmetics ensure stable sales

Read more

Alcina hair division and caring cosmetics ensure stable sales

In 2020, Bielefeld-based Dr. Wolff Group recorded an increase of almost nine percent with sales of 341.1 million euros (2019: 313.4 million). With 40.9 million euros in revenue (2019: 44.1 million) Alcina contributed a 12 per cent share to the group's total revenue in 2020.

Read more

Dr. August Wolff and Cantabria Labs enter into an exclusive commercialization agreement for Southern Europe for hyperhidrosis product

Read more
13.04.2021

Dr. August Wolff and Cantabria Labs enter into an exclusive commercialization agreement for Southern Europe for hyperhidrosis product

Promising German-Spanish partnership between Dr. August Wolff GmbH & Co. KG Arzneimittel and Cantabria Labs officially sealed.

Read more

Dr. August Wolff Submits Application for Marketing Authorization of 1% Glycopyrronium Bromide (GPB) Cream in the EU – Positive Phase 3a Part of Pivotal Study Results for 1% GPB Cream in Patients with Primary Axillary Hyperhidrosis

Read more
22.03.2021

Dr. August Wolff Submits Application for Marketing Authorization of 1% Glycopyrronium Bromide (GPB) Cream in the EU – Positive Phase 3a Part of Pivotal Study Results for 1% GPB Cream in Patients with Primary Axillary Hyperhidrosis

The Bielefeld-based family-owned pharmaceutical developing and manufacturing company Dr. August Wolff GmbH & Co. KG Arzneimittel (“Dr. August Wolff”) announces that the “Marketing Authorisation Application” (MAA) for 1% Glycopyrronium bromide (GPB) cream was submitted on February 26th to the Medical Products Agency (MPA, Sweden) despite the challenges of the COVID-19 pandemic.

Read more

First medical anti-COVID-19 mouth and throat wash with laboratory and clinical data

Read more
25.02.2021

First medical anti-COVID-19 mouth and throat wash with laboratory and clinical data

Based on their know-how in the field of oral hygiene, Dr. Wolff presents with Linola® sept mouth and throat wash for the first time a product, which has been confirmed in its effectivness against the corona virus in several laboratory and additional clinical test results.

Read more